Pharma Services
Pharmaceutical and biotechnology companies continue to outsource development, manufacturing, and commercialization activities, supporting durable demand for specialized service providers across the drug lifecycle.
The buyer universe includes global CROs and CDMOs, strategic acquirers building end-to-end platforms, and private equity firms with deep healthcare franchises. The strongest outcomes are generally achieved by businesses with differentiated scientific or regulatory capabilities, embedded multi-year customer relationships, recurring or milestone-backed revenue, and strong quality track records. Buyers will also evaluate customer and program concentration, therapeutic-area exposure, capacity utilization, technical talent depth, and the durability of demand as pipelines and funding environments shift.
Focus areas
- Clinical research & trial services
- Contract development & manufacturing
- Commercialization & patient support
- Regulatory & quality consulting
- Specialty pharmacy & distribution
Featured deal
Has been acquired by
Fit For Work